Insulet Corp. (PODD)
285.34
-1.69
(-0.59%)
USD |
NASDAQ |
Dec 31, 13:03
Insulet Free Cash Flow: 407.70M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tandem Diabetes Care, Inc. | -25.12M |
| Boston Scientific Corp. | 3.824B |
| Intuitive Surgical, Inc. | 2.271B |
| Abbott Laboratories | 6.917B |
| Globus Medical, Inc. | 569.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 125.70M |
| Cash from Investing (Quarterly) | -31.00M |
| Cash from Financing (Quarterly) | -457.00M |
| Free Cash Flow Per Share (Quarterly) | 1.339 |
| Free Cash Flow to Equity (Quarterly) | 480.70M |
| Free Cash Flow to Firm (Quarterly) | 105.73M |
| Free Cash Flow Yield | 1.97% |